Most Recent
Aristocrat has sued competitor Light & Wonder and two former employees for allegedly using confidential information about its popular Dragon Link poker game to develop a competing product.
Fortescue has defeated a bid by its former CFO’s green iron start-up to set aside search orders that were said to have been secured “off the back of egregious material non-disclosure”.
US drug giant Eli Lilly cannot register a trade mark consisting of the word 'hair' preceded by the 'greater-than' symbol, despite winning registration in the UK, Switzerland and New Zealand.
The developer of the blockbuster horror video game Dead by Daylight has succeeded in revoking the trade mark of rival developer of a virtual sporting game.
A founder and former principal at a Sydney intellectual property firm has made the switch to Dentons, filling out the firm's Australasian patents team.
Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug.
The developer of a Canola seed hybrid tolerant to herbicide has lost a bid for seed grower Nuseed to relabel its products, which are already stocked in 361 retail locations.
Sydney hospitality mogul Justin Hemmes has prevailed in a trade mark stoush with Brisbane restaurant Establishment 203.
Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.
Cosmetics maker Self Care has won its case against companies with ties to China that were found to have sold counterfeit versions of its popular Freezeframe anti-ageing creams.